The discovery and preclinical characterization of the MTA cooperative PRMT5 inhibitor AM-9747

被引：0

作者：

Belmontes, Brian ^{[1
]}

Policheni, Antonia ^{[1
]}

Liu, Siyuan ^{[1
]}

Slemmons, Katherine ^{[1
]}

Moriguchi, Jodi ^{[1
]}

Ma, Hayley ^{[1
]}

Aiello, Daniel ^{[1
]}

Yang, Yajing ^{[1
]}

Vestergaard, Mikkel ^{[2
]}

Cowland, Sanne ^{[2
]}

Anderson, Jan ^{[2
]}

Sarvary, Ian ^{[2
]}

Tamayo, Nuria ^{[1
]}

Pettus, Liping ^{[1
]}

Mukund, Susmith ^{[3
]}

Pope, Leszek ^{[1
]}

Allen, Jennifer R. ^{[1
]}

Glad, Sanne ^{[2
]}

Bourbeau, Matthew ^{[1
]}

Hughes, Paul E. ^{[1
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA USA

[2] Amgen Inc, Copenhagen, Denmark

[3] Amgen Inc, San Francisco, CA USA

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1807

引用

页数：2

共 50 条

[1] From DNA-Encoded Library Screening to AM-9747: An MTA-Cooperative PRMT5 Inhibitor with Potent Oral In Vivo Efficacy
Sarvary, Ian
Vestergaard, Mikkel
Moretti, Loris
Andersson, Jan
Cadahia, Jorge Peiro
Cowland, Sanne
Flagstad, Thomas
Franch, Thomas
Gouliaev, Alex
Husemoen, Gitte
Jacso, Tomas
Kronborg, Titi
Kuropatnicka, Aleksandra
Nadali, Anna
Madsen, Mads
Nielsen, Soren
Pii, David
Ryborg, Soren
Soede, Camillia
Allen, Jennifer R.
Bourbeau, Matthew
Li, Kexue
Liu, Qingyian
Lo, Mei-Chu
Madoux, Franck
Mardirossian, Narbe
Moriguchi, Jodi
Ngo, Rachel
Peng, Chi-Chi
Pettus, Liping
Tamayo, Nuria
Wang, Paul
Kapoor, Rajiv
Belmontes, Brian
Caenepeel, Sean
Hughes, Paul
Liu, Siyuan
Slemmons, Katherine K.
Yang, Yajing
Xie, Fang
Ghimire-Rijal, Sudipa
Mukund, Susmith
Glad, Sanne
JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (06) : 6534 - 6557
[2] iscovery and characterization of an MTA-cooperative and brain-penetrant PRMT5 inhibitor
Pan, Welling
Wang, Hui
Qi, Fangfei
Deng, Haibing
Yang, Fei
Yu, Hongping
Xu, Yao-Chang
Chen, Zhui
Ying, Haiyan
MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
[3] Preclinical characterization of ABSK131, a potential best-in-class MTA-cooperative PRMT5 inhibitor
Pan, W.
Wang, H.
Qi, F.
Deng, H.
Yu, H.
Xu, Y. C.
Chen, Z.
Ying, H.
EUROPEAN JOURNAL OF CANCER, 2024, 211 : S17 - S18
[4] Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers
Pettus, Liping H.
Bourbeau, Matthew
Tamayo, Nuria A.
Amegadzie, Albert
Beylkin, Diane
Booker, Shon K.
Butler, John
Frohn, Michael J.
Kaller, Matthew R.
Kohn, Todd
Lanman, Brian A.
Li, Kexue
Liu, Qingyian
Ma, Vu
Medina, Jose
Minatti, Ana E.
Lopez, Patricia
Manoni, Francesco
Pickrell, Alex
Weires, Nicholas
Andersson, Jan
Cowland, Sanne
Glad, Sanne
Sarvary, Ian
Vestergaard, Mikkel
Li, Weikun
Ghimire-Rijal, Sudipa
Mardirossian, Narbe
Mukund, Susmith
Chen, Qing
Lo, Mei-Chu
Ngo, Rachel
Khetan, Jawahar
Madoux, Franck
Sanders, Christiana
Sharma, Pooja
Wang, Paul
Bruenner, Bernd
Mccloud, Stuart
Ponce, Manuel
Soto, Marcus
Wahlstrom, Jan
Xie, Fang
Yang, Yajing
Liu, Siyuan
Tan, Hong
Policheni, Antonia
Caenepeel, Sean
Slemmons, Katherine K.
Belmontes, Brian
JOURNAL OF MEDICINAL CHEMISTRY, 2025,
[5] The discovery and preclinical characterization of AMG 193, a first-in-class MTA-cooperative PRMT5 inhibitor with broad activity against MTAP-null cancers
Bojko-Matuszek, Agnieszka
Kolakowski, Damian
Bojko, Magdalena
Sowinska, Aleksandra
Mitula, Filip
Lacek, Krzysztof
Popiel, Delfina
Kwiatkowski, Sebastian
Kornatowski, Tomasz
Kliszcz, Beata
Jablonska, Anna
Flis, Krzysztof
Wiernicki, Bartosz
Wieczorek, Maciej
Pieczykolan, Jerzy
Abramczyk, Olga
MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
[6] The discovery and preclinical characterization of the SAM-competitive PRMT5 inhibitor UCT-000445
McDermott, Martina S.
O'Brien, Neil A.
O'Boyle, Brendan
Bartberger, Michael
Loson, Oliver C.
Chau, Kevin
Schwab, Ella
Hong, Jenny
Zhou, Jiaying
Hu, Chuhong
Luo, Tong
Ayala, Raul
Glasby, John
Stoltz, Brian M.
Slamon, Dennis J.
CANCER RESEARCH, 2023, 83 (07)
[7] A review of the known MTA-cooperative PRMT5 inhibitors
Hu, Mei
Chen, Xiang
RSC Advances, 2024, 14 (53) : 39653 - 39691
[8] Discovery of highly selective novel MTA-cooperative PRMT5 inhibitors for the treatment of cancers
Wu, Wen-Lian
Hu, Taishan
Deng, Zhilin
Li, Honghai
Shen, Quanrong
Zhang, Lei
Ma, Xiaochu
Sun, Peihua
Cheng, Cindy
Liu, Fang
Chen, Xin
Hua, Ye
Huang, Bryan
CANCER RESEARCH, 2024, 84 (06)
[9] TNG908, a brain-penetrant MTA-cooperative PRMT5 inhibitor, is efficacious in preclinical glioblastoma models
Zhang, Minjie
Tsai, Alice
Cottrell, Kevin M.
Haines, Brian B.
Wilker, Erik
DiBenedetto, Heather
Weitzman, Ron
Huang, Alan
Davis, Charles B.
Maxwell, John P.
Briggs, Kimberly J.
CANCER RESEARCH, 2023, 83 (07)
[10] Discovery and In Vivo Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity
Smith, James M.
Barlaam, Bernard
Beattie, David
Bradshaw, Lauren
Chan, Ho Man
Chiarparin, Elisabetta
Collingwood, Olga
Cooke, Sophie L.
Cronin, Anna
Cumming, Iain
Dean, Emma
Debreczeni, Judit E.
del Barco Barrantes, Ivan
Diene, Coura
Gianni, Davide
Guerot, Carine
Guo, Xiaoxiao
Guven, Sinem
Hayhow, Thomas G.
Hong, Ted
Kemmitt, Paul D.
Lamont, Gillian M.
Lamont, Scott
Lynch, James T.
McWilliams, Lisa
Moore, Shaun
Raubo, Piotr
Robb, Graeme R.
Robinson, James
Scott, James S.
Srinivasan, Bharath
Steward, Oliver
Stubbs, Christopher J.
Syson, Karl
Tan, Lixiang
Turner, Oliver
Underwood, Elizabeth
Urosevic, Jelena
Vazquez-Chantada, Mercedes
Whittaker, Amy L.
Wilson, David M.
Winter-Holt, Jon J.
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (16) : 13604 - 13638

← 1 2 3 4 5 →